Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.

beta-2 microglobulin levels were measured in stored serum taken at presentation from 262 patients treated with combination chemotherapy for Kiel classification high-grade lymphoma at a single centre over a 15 year period. A significant association was found between elevated levels and advanced (Ann...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, P. W., Whelan, J., Longhurst, S., Stepniewska, K., Matthews, J., Amess, J., Norton, A., Rohatiner, A. Z., Lister, T. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968369/
https://www.ncbi.nlm.nih.gov/pubmed/8471438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968369/
https://www.ncbi.nlm.nih.gov/pubmed/8471438

Ejemplares similares